LXRX LEXICON PHARMACEUTICALS INC

Ownership history in COMMONWEALTH EQUITY SERVICES, LLC  ·  29 quarters on record

This page tracks every 13F SEC filing in which COMMONWEALTH EQUITY SERVICES, LLC reported a position in LEXICON PHARMACEUTICALS INC (LXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 35,738 -55,126 -60.7% 0.00% $48K $1.35
2025 Q2 UNCHANGED 90,864 0% 0.00% $86K $0.95
2025 Q1 REDUCED 90,864 -10,284 -10.2% 0.00% $42K $0.46
2024 Q4 REDUCED 101,148 -7,586 -7.0% 0.00% $75K $0.74
2024 Q3 ADDED 108,734 +7,600 +7.5% 0.00% $171K $1.57
2024 Q2 ADDED 101,134 +5,950 +6.3% 0.00% $170K $1.68
2024 Q1 ADDED 95,184 +61,000 +178.4% 0.00% $228K $2.40
2023 Q4 REDUCED 34,184 -5,385 -13.6% 0.00% $52K $1.53
2023 Q3 ADDED 39,569 +24,400 +160.9% 0.00% $43K $1.09
2023 Q2 ADDED 15,169 +1,100 +7.8% 0.00% $35K $2.29
19 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LXRX price (monthly, adj. close)
← Back to COMMONWEALTH EQUITY SERVICES, LLC Holdings